Companies: 49,246 Total Market Cap: 132441797263938.02

Kolon TissueGene

KOSDAQ-950160

Biological Products, Except Diagnostic Substances

Rank #5734

Market Cap 2.14 B

Volume 483,418

Price 26.20

Change (%) 10.84%

Country or region

United States

Kolon TissueGene's latest marketcap:

2.14 B

As of 05/20/2025, Kolon TissueGene's market capitalization has reached $2.14 B. According to our data, Kolon TissueGene is the 5734th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	2.14 B
Revenue (ttm)	0
Net Income (ttm)	0
Shares Out	81.60 M
EPS (ttm)	0
Forward PE	0.00
Ex-Dividend Date	n/a
Earnings Date	n/a

Market Cap Chart

Data Updated: 05/20/2025

Kolon TissueGene's yearly market capitalization.

Kolon TissueGene has seen its market value grow from ₩612.43 B to ₩3.00 T since 2022, representing a total increase of 390.33% and an annual compound growth rate (CAGR) of 94.39%.

Date	Market Cap	Change (%)
05/20/2025	₩3.00 T	49.8%
12/30/2024	₩1.85 T	181.73%
12/28/2023	₩655.80 B	7.08%
12/29/2022	₩612.43 B

Company Profile

About Kolon TissueGene, Inc.

Kolon TissueGene, Inc. is a biotechnology company specializing in the development of innovative cell therapies for orthopedic and degenerative diseases.

Key Focus Areas

Orthopedic Therapies: Targeting osteoarthritis and musculoskeletal disorders.
Veterinary Medicine: Expanding applications of cell therapies to animal health.

Company Background

Founded in 1999, Kolon TissueGene, Inc. was originally known as TissueGene, Inc. before rebranding in March 2018. The company is headquartered in Rockville, Maryland.

Frequently Asked Questions

As of 05/20/2025, Kolon TissueGene (including the parent company, if applicable) has an estimated market capitalization of $2.14 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Kolon TissueGene global market capitalization ranking is approximately 5734 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	United States
Founded	1999
IPO Date	n/a
Employees	29
CEO	Moon-jong Noh
Sector
Industry	Biological Products, Except Diagnostic Substances
Address	9713 Key West Avenue Rockville, Delaware 20850 United States
Website	https://www.tissuegene.com